• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    • Overview
    • Buy Sell Zone
    • Financials
    • News
      All News Earnings Calls Corporate Announcements Research Reports
    • Reports
    • Technicals
      Technicals Share Price History Delivery
    • Shareholding
      Shareholding Monthly MF Holdings Bulk Block Deals Insider Trading & SAST
    • Deals
      Bulk Block Deals Insider Trading & SAST
    • Corporate Actions
      All Dividend Bonus Split Rights Board Meetings
    • Alerts
    • About

    Shilpa Medicare Ltd.

    NSE: SHILPAMED | BSE: 530549 | ISIN: INE790G01031 | Industry: Pharmaceuticals
    Drug Approval
    | Mid-range Performer
    824.8500 6.40 (0.78%)
    NSE Sep 23, 2025 15:31 PM
    48.62% Gain from 52W Low
    Volume: 352.2K
    High volume today
    • Share on Facebook
    • Tweet
    • Share on LinkedIn
    • Share via Whatsapp

    logo
    Shilpa Medicare Ltd.
    30 May 2015
    Drug Approval
    824.85
    0.78%

    Shilpa Medicare Ltd: Q4FY15 Results First Cut - Flat Revenues With Improved Prof... (May 30, 2015)

    buy
    Shilpa Medicare Ltd.
    by Karvy
    Karvy
    The Q4FY15 revenue declined by 0.4% YoY and grew at 7.9% QoQ. The company has maintained the revenue growth achieved in FY14 (at 54% YoY) at 7.4% YoY for FY15. The company's ascent in operating margins continues as it reported an EBITDA margin of 22.7% in Q4FY15, an increase of 87 bps QoQ and 147 bps YoY
    Copy Link Share on Share on Share on Share on
    Alert  
    Shilpa Medicare Ltd. is trading above its 200 day SMA of 783.9
    More from Shilpa Medicare Ltd.
    Recommended
    Five stocks to buy from analysts this week - September 23, 2025
    The Baseline | 23 Sep 2025, 06:11PM
    Market closes lower, Tata Motors’ JLR extends production halt till Oct 1
    Trendlyne Marketwatch | 23 Sep 2025, 03:57PM
    Top Gainers in the News: Shilpa Medicare, Ujjivan Financial Services, Swan Energy, Godrej Properties, Au Small Finance Bank
    | 05 Feb 2020
    Trendlyne Logo Trendlyne
    Stay ahead of the market
    Markets Today
    • Nifty 50 today
    • Sensex today
    • Latest Quarterly results
    • FII & DII data today
    Dashboard
    • Industry & Sector analysis
    • ETFs
    • Mutual Funds
    • Bullish & Bearish spread
    • Global Indices
    Tools
    • Compare stocks
    • Widgets
    • Data Downloader
    • Excel Connect
    IPOs
    • Dashboard (Mainboard & SME)
    • Upcoming IPOs
    • Recently Listed IPOs
    • Most Successful IPOs
    Upcoming IPOs
    • GK Energy
    • Siddhi Cotspin
    • Saatvik Green Energy
    Quick Links
    • Contact us
    • Blogs
    • FAQs
    Company
    • Privacy
    • Terms of Use
    • Disclaimer
    Trendlyne Products
    • Starfolio
    • SmartOptions
    • Trendlyne US Global
    Get Mobile App
    • Android
    • iOS

    Copyright © 2025 Giskard Datatech Pvt Ltd